Status:
UNKNOWN
Biomarkers for Identification of COVID-19 Infection
Lead Sponsor:
University of Catanzaro
Collaborating Sponsors:
Azienda Ospedaliera Pugliese Ciaccio
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Conditions:
Coronavirus
Eligibility:
All Genders
14-75 years
Brief Summary
Acute lung injury represents the most severe form of the viral infection sustained by coronavirus disease 2019 (Covid-19) also named as SARS-CoV-2, a new virus emerged in December 2019 in Wuhan (China...
Eligibility Criteria
Inclusion
- Aged between 18 and 75 years, extremes included, male or female In conscious patients, ability to understand and the willingness to sign a written informed consent document; in unconscious patients informed consent will be signed from parents or legal tutors.
Exclusion
- Patients that don't sign the informed consent
Key Trial Info
Start Date :
March 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04322513
Start Date
March 24 2020
End Date
December 30 2022
Last Update
October 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Luca Gallelli
Catanzaro, Italy, 88100